Literature DB >> 9862306

Osteogenesis imperfecta in childhood: treatment strategies.

R H Engelbert1, H E Pruijs, F A Beemer, P J Helders.   

Abstract

Osteogenesis imperfecta (OI) is a skeletal disorder of remarkable clinical variability characterized by bone fragility, osteopenia, variable degrees of short stature, and progressive skeletal deformities. Additional clinical manifestations such as blue sclerae, dentinogenesis imperfecta, joint laxity, and maturity onset deafness are described in the literature. OI occurs in about 1 in 20,000 births and is caused by quantitative and qualitative defects in the synthesis of collagen I. Depending on the severity of the disease, a large impact on motor development, range of joint motion, muscle strength, and functional ability may occur. Treatment strategies should primarily focus on the improvement of functional ability and the adoption of compensatory strategies, rather than merely improving range of joint motion and muscle strength. Surgical treatment of the extremities may be indicated to stabilize the long bones to optimize functional ability and walking capacity. Surgical treatment of the spine may be indicated in patients with progressive spinal deformity and in those with symptomatic basilar impression.

Entities:  

Mesh:

Year:  1998        PMID: 9862306     DOI: 10.1016/s0003-9993(98)90426-9

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  14 in total

Review 1.  Treatment of children with osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Curr Osteoporos Rep       Date:  2006-12       Impact factor: 5.096

2.  Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study.

Authors:  Keren Machol; Trevor D Hadley; Jake Schmidt; David Cuthbertson; Henri Traboulsi; Rodrigo C Silva; Chloe Citron; Sobiah Khan; Kate Citron; Erin Carter; Kenneth Brookler; Jay R Shapiro; Robert D Steiner; Peter H Byers; Francis H Glorieux; Michaela Durigova; Peter Smith; Michael B Bober; Vernon R Sutton; Brendan H Lee; Sandesh C S Nagamani; Cathleen Raggio
Journal:  Am J Med Genet A       Date:  2019-12-26       Impact factor: 2.802

3.  [Osteogenesis imperfecta].

Authors:  M Salzmann; C Krohn; N Berger
Journal:  Orthopade       Date:  2014-08       Impact factor: 1.087

Review 4.  Tooth dentin defects reflect genetic disorders affecting bone mineralization.

Authors:  S Opsahl Vital; C Gaucher; C Bardet; P S Rowe; A George; A Linglart; C Chaussain
Journal:  Bone       Date:  2012-01-26       Impact factor: 4.398

Review 5.  Osteogenesis imperfecta: practical treatment guidelines.

Authors:  F Antoniazzi; M Mottes; P Fraschini; P C Brunelli; L Tatò
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

6.  Mobility in osteogenesis imperfecta: a multicenter North American study.

Authors:  Karen M Kruger; Angela Caudill; Mercedes Rodriguez Celin; Sandesh C S Nagamani; Jay R Shapiro; Robert D Steiner; Michael B Bober; Tracy Hart; David Cuthbertson; Jeff Krischer; Peter H Byers; Michaela Durigova; Francis H Glorieux; Frank Rauch; V Reid Sutton; Brendan Lee; Eric T Rush; Peter A Smith; Gerald F Harris
Journal:  Genet Med       Date:  2019-03-28       Impact factor: 8.822

7.  Current and emerging treatments for the management of osteogenesis imperfecta.

Authors:  Elena Monti; Monica Mottes; Paolo Fraschini; Piercarlo Brunelli; Antonella Forlino; Giacomo Venturi; Francesco Doro; Silvia Perlini; Paolo Cavarzere; Franco Antoniazzi
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

8.  Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta.

Authors:  F de Graaff; W Verra; J E H Pruijs; R J B Sakkers
Journal:  J Child Orthop       Date:  2011-01-25       Impact factor: 1.548

9.  Osteogenesis imperfecta type I: A case report.

Authors:  Jianmin Ren; Xiaojie Xu; Xiangdong Jian; Jieru Wang
Journal:  Exp Ther Med       Date:  2014-03-31       Impact factor: 2.447

10.  The dentin phosphoprotein repeat region and inherited defects of dentin.

Authors:  Jie Yang; Kazuhiko Kawasaki; Moses Lee; Bryan M Reid; Stephanie M Nunez; Murim Choi; Figen Seymen; Mine Koruyucu; Yelda Kasimoglu; Ninna Estrella-Yuson; Brent P J Lin; James P Simmer; Jan C-C Hu
Journal:  Mol Genet Genomic Med       Date:  2015-09-07       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.